Panel Discussion: Driving Patient Selection with Digital Pathology for Streamlined Clinical Trials
Time: 9:30 am
day: Conference Day Two
Details:
- How can digital pathology improve the identification and stratification of patients for biomarker-driven therapies, and where is it already making a measurable impact?
- What steps should biopharma take to integrate digital pathology into trial design early, so it meaningfully contributes to patient enrichment, rather than becoming an afterthought?
- What are the key considerations when validating digital pathology as a patient selection tool for CDx use, particularly in terms of model generalizability and clinical utility?
Speakers:
